Abstract
Leishmania (L.) tropica is a causative agent of cutaneous and occasionally visceral or viscerotropic leishmaniasis in humans. The dose of parasites influences the course and outcome of disease in some Leishmania species. The effect of parasite dose on L. tropica infection in an experimental model was studied in the current paper. High and low doses of L. tropica were used for ear infection of BALB/c mice and lesion development, parasite load, and cytokine responses were assessed. L. major infection was used for comparison. Pre-infected mice were challenged in the footpad by a fixed high dose of L. tropica, and immune response and protection level were evaluated. High dose L. tropica infection in comparison to low dose results in higher lesion diameters, higher load of parasite in draining lymph node, higher levels of interferon-γ and interleukin-10, dissemination of parasite to spleen, and induction of protection against further L. tropica challenge. Comparison of L. tropica with L. major showed that L. tropica results in lower lesion diameters, more potential for growth in lymph nodes at early phases of infection, parasite dissemination to spleen, lower levels of IL-10, and a permanent lower cytokine response against low parasite dose in comparison to high dose. Our findings suggest that for L. tropica infection, only the high dose results in visceralization of the parasite and protection against further challenge of L. tropica. Therefore, the parasite dose may be an important factor in pathogenesis and immunity in L. tropica infection.
Similar content being viewed by others
References
Alborzi A, Rasouli M, Shamsizadeh A (2006) Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 74:306–307
Bastien P, Killick-Kendrick R (1992) Leishmania tropica infection in hamsters and a review of the animal pathogenicity of this species. Exp Parasitol 75:433–441
Bogdan C, Nathan C (1993) Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685:713–739
Chatelain R, Mauze S, Coffman RL (1999) Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 21:211–218
Compton HL, Farrell JP (2002) CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J Immunol 168:1302–1308
Courtenay O, Peters NC, Rogers ME, Bern C (2017) Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control. PLoS Pathog 13:e1006571
Doherty TM, Coffman RL (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol 84:124–135
Eroglu F, Koltas IS, Alabaz D, Uzun S, Karakas M (2015) Clinical manifestations and genetic variation of Leishmania infantum and Leishmania tropica in Southern Turkey. Exp Parasitol 154:67–74
Hosken NA, Shibuya K, Heath AW, Murphy KM, O’Garra A (1995) The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 182:1579–1584
Kane MM, Mosser DM (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166:1141–1147
Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V (2008) Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413–1419
Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D (2008) Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A 105:10125–10130
Lira R, Mendez S, Carrera L, Jaffe C, Neva F, Sacks D (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89:331–342
Lira R, Doherty M, Modi G, Sacks D (2000) Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect Immun 68:5176–5182
Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN (1993) Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328:1383–1387
Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D (2007) Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean J Parasitol 45:247–253
Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M, Moradi M, Alimohammadian M, Parvizi P, Hatam G, Mohebali M, Khalaj V (2011a) The problem of mixing up of Leishmania isolates in the laboratory: suggestion of ITS1 gene sequencing for verification of species. Iran J Parasitol 6:41–48
Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D (2011b) Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice. Exp Parasitol 127:448–453
Menon JN, Bretscher PA (1998) Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol 28:4020–4028
Noben-Trauth N, Lira R, Nagase H, Paul WE, Sacks DL (2003) The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170:5152–5158
Oliveira DM, Costa MA, Chavez-Fumagalli MA, Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M, Tavares CA, Coelho EA (2012) Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Parasitol Res 110:1277–1285
Ribeiro-Gomes FL, Roma EH, Carneiro MB, Doria NA, Sacks DL, Peters NC (2014) Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major. Infect Immun 82:2713–2727
Ribeiro-Romao RP, Moreira OC, Osorio EY, Cysne-Finkelstein L, Gomes-Silva A, Valverde JG, Pirmez C, Da-Cruz AM, Pinto EF (2014) Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations. Infect Immun 82:5203–5213
Rostamian M, Sohrabi S, Kavosifard H, Niknam HM (2017) Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice. J Microbiol Immunol Infect 50:160–166
Sacks D, Anderson C (2004) Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201:225–238
Sacks DL, Melby PC (2015) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 108:1921–1924
Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845–858
Simonian MH, Smith JA (2006) Spectrophotometric and colorimetric determination of protein concentration. Curr Protoc Mol Biol Chapter 10:Unit 10 11A
Stober CB, Lange UG, Roberts MT, Alcami A, Blackwell JM (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175:2517–2524
Streit JA, Recker TJ, Filho FG, Beverley SM, Wilson ME (2001) Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. J Immunol 166:1921–1929
Uzonna JE, Joyce KL, Scott P (2004) Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med 199:1559–1566
Warburg A, Schlein Y (1986) The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am J Trop Med Hyg 35:926–930
Acknowledgements
Critical readings of this paper by Mary E. Wilson (University of Iowa, Iowa City, USA) and Mohammad H. Alimohammadian (Pasteur Institute of Iran, Tehran, Iran) are highly appreciated.
Funding
This research received financial support from PhD scholarship to M. Rostamian, Pasteur Institute of Iran (Research project No. 595), and Iran National Science Foundation (grant No. 93035899).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Rostamian, M., Jafari, D., Abolghazi, M. et al. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model. Parasitol Res 117, 2949–2956 (2018). https://doi.org/10.1007/s00436-018-5991-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-018-5991-7